help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on March 18, 2005, doi:10.1164/rccm.200502-257OE

Am. J. Respir. Crit. Care Med., Volume 171, Number 11, June 2005, 1202-1208

A more recent version of this article appeared on June 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200502-257OEv1
171/11/1202    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, E. K
Right arrow Articles by Drazen, J. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, E. K
Right arrow Articles by Drazen, J. M

Submitted on February 16, 2005
Accepted on March 16, 2005

Asthma: One Hundred Years of Treatment and Onward

Eric K Chu1 and Jeffrey M Drazen1*

1 Department of Medicine, Pulmonary Division, Brigham and Women's Hospital, Boston, MA, United States

* To whom correspondence should be addressed. E-mail: jdrazen{at}nejm.org.

There have been four types of drug treatment of asthma that have been employed over the past 100 years. Belladonna alkaloids, derived from the thornapple plant were used in 1905 and chemically synthesized entities in this class are still in use today. Western medicine began to use adrenergic stimulants about 100 years ago, but they were likely used in Asian medicine long before that. Systemic treatment with corticosteroids was introduced into the treatment of asthma in the mid twentieth century, inhaled corticosteroids have been in use for over 35 years. The last 40 years have also seen the development of the first targeted asthma treatments-cromones, anti-leukotrienes and anti-IgE. As we learn more of the biology of asthma, we anticipate that more effective targeted asthma treatments will be developed.


Key words: asthma, anticholinergic, adrenergic, corticosteroid




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. E. Korf, G. Pynaert, K. Tournoy, T. Boonefaes, A. Van Oosterhout, D. Ginneberge, A. Haegeman, J. A. Verschoor, P. De Baetselier, and J. Grooten
Macrophage Reprogramming by Mycolic Acid Promotes a Tolerogenic Response in Experimental Asthma
Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 152 - 160.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 698 - 706.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  ATS Clinical Skills Tests